194 related articles for article (PubMed ID: 12424225)
1. Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila.
Micchelli CA; Esler WP; Kimberly WT; Jack C; Berezovska O; Kornilova A; Hyman BT; Perrimon N; Wolfe MS
FASEB J; 2003 Jan; 17(1):79-81. PubMed ID: 12424225
[TBL] [Abstract][Full Text] [Related]
2. Endoproteolysis of the ER stress transducer ATF6 in the presence of functionally inactive presenilins.
Steiner H; Winkler E; Shearman MS; Prywes R; Haass C
Neurobiol Dis; 2001 Aug; 8(4):717-22. PubMed ID: 11493036
[TBL] [Abstract][Full Text] [Related]
3. Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.
Lewis HD; Pérez Revuelta BI; Nadin A; Neduvelil JG; Harrison T; Pollack SJ; Shearman MS
Biochemistry; 2003 Jun; 42(24):7580-6. PubMed ID: 12809514
[TBL] [Abstract][Full Text] [Related]
4. C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester).
Morohashi Y; Kan T; Tominari Y; Fuwa H; Okamura Y; Watanabe N; Sato C; Natsugari H; Fukuyama T; Iwatsubo T; Tomita T
J Biol Chem; 2006 May; 281(21):14670-6. PubMed ID: 16569643
[TBL] [Abstract][Full Text] [Related]
5. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
[TBL] [Abstract][Full Text] [Related]
6. gamma-Secretase inhibitors as molecular probes of presenilin function.
Wolfe MS
J Mol Neurosci; 2001 Oct; 17(2):199-204. PubMed ID: 11816793
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of gamma-secretase activities through high molecular weight complex formation of presenilins is conserved in Drosophila melanogaster and mammals.
Takasugi N; Takahashi Y; Morohashi Y; Tomita T; Iwatsubo T
J Biol Chem; 2002 Dec; 277(51):50198-205. PubMed ID: 12388554
[TBL] [Abstract][Full Text] [Related]
8. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease.
Wolfe MS; De Los Angeles J; Miller DD; Xia W; Selkoe DJ
Biochemistry; 1999 Aug; 38(35):11223-30. PubMed ID: 10471271
[TBL] [Abstract][Full Text] [Related]
9. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.
De Strooper B; Annaert W; Cupers P; Saftig P; Craessaerts K; Mumm JS; Schroeter EH; Schrijvers V; Wolfe MS; Ray WJ; Goate A; Kopan R
Nature; 1999 Apr; 398(6727):518-22. PubMed ID: 10206645
[TBL] [Abstract][Full Text] [Related]
10. The presenilins in Alzheimer's disease--proteolysis holds the key.
Haass C; De Strooper B
Science; 1999 Oct; 286(5441):916-9. PubMed ID: 10542139
[TBL] [Abstract][Full Text] [Related]
11. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.
Esler WP; Kimberly WT; Ostaszewski BL; Diehl TS; Moore CL; Tsai JY; Rahmati T; Xia W; Selkoe DJ; Wolfe MS
Nat Cell Biol; 2000 Jul; 2(7):428-34. PubMed ID: 10878808
[TBL] [Abstract][Full Text] [Related]
12. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
[TBL] [Abstract][Full Text] [Related]
13. Implication of APP secretases in notch signaling.
Hartmann D; Tournoy J; Saftig P; Annaert W; De Strooper B
J Mol Neurosci; 2001 Oct; 17(2):171-81. PubMed ID: 11816790
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological analysis of Drosophila melanogaster gamma-secretase with respect to differential proteolysis of Notch and APP.
Groth C; Alvord WG; Quiñones OA; Fortini ME
Mol Pharmacol; 2010 Apr; 77(4):567-74. PubMed ID: 20064975
[TBL] [Abstract][Full Text] [Related]
16. A sensitive and quantitative assay for measuring cleavage of presenilin substrates.
Karlström H; Bergman A; Lendahl U; Näslund J; Lundkvist J
J Biol Chem; 2002 Mar; 277(9):6763-6. PubMed ID: 11744687
[TBL] [Abstract][Full Text] [Related]
17. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants.
Ye Y; Lukinova N; Fortini ME
Nature; 1999 Apr; 398(6727):525-9. PubMed ID: 10206647
[TBL] [Abstract][Full Text] [Related]
18. Identifying genes that interact with Drosophila presenilin and amyloid precursor protein.
van de Hoef DL; Hughes J; Livne-Bar I; Garza D; Konsolaki M; Boulianne GL
Genesis; 2009 Apr; 47(4):246-60. PubMed ID: 19241393
[TBL] [Abstract][Full Text] [Related]
19. Structure, mechanism and inhibition of gamma-secretase and presenilin-like proteases.
Wolfe MS
Biol Chem; 2010 Aug; 391(8):839-47. PubMed ID: 20482315
[TBL] [Abstract][Full Text] [Related]
20. Presenilin-dependent gamma-secretase activity modulates neurite outgrowth.
Figueroa DJ; Morris JA; Ma L; Kandpal G; Chen E; Li YM; Austin CP
Neurobiol Dis; 2002 Feb; 9(1):49-60. PubMed ID: 11848684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
